Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Aug 13, 2019
Q2 2019 Revenue of $1.65 million, a 20% decline from Q2 2018 Record 1H 2019 Revenue of $3.89 million, a 2% increase over 1H 2018 Expense shift from D2C to B2B, resulting in a short-term decline in...
-
Aug 12, 2019Dario Membership users with diabetes achieved a 39% increase of in-range, blood-glucose measurements
DarioHealth Corp. (NASDAQ: DRIO) ("DarioHealth" or "Dario"), a leading global, digital therapeutics company, presented new clinical data yesterday at the American Association of Diabetes Educators...
-
Aug 7, 2019Earnings Discussion and Business Update Scheduled for 9:00 am EDT
Global digital therapeutics innovation leader DarioHealth Corp. (NASDAQ: DRIO) today announced it will release its second quarter 2019 results on Tuesday, August 13, and host a conference call the...
-
Aug 6, 2019- Data further underscores clinical evidence of overall health improvement for type 2 Diabetes users of DarioHealth app
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or "Dario"), a leading global, digital therapeutics company and member of the Digital Therapeutics Alliance (DTx), today announced its plan to...
-
Jul 30, 2019New offering enables users to integrate blood pressure readings into the Dario mobile app to gain better understanding and control of overall health.
DarioHealth Corp. (Nasdaq: DRIO), ("DarioHealth" or "Dario"), a leading global, digital therapeutics company, announced today the addition of a new digital monitoring solution on its Dario app...
-
Jul 25, 2019DarioHealth offers USB-C connector configuration between Android smart mobile devices and the Dario Blood Glucose Meter
Global digital therapeutics innovator DarioHealth Corp. (Nasdaq: DRIO), today announced that its CE certificate covers a USB-C connector enabled version of the acclaimed Dario™ Blood Glucose...
Jul 8, 2019Global digital therapeutics innovator DarioHealth Corp. (Nasdaq: DRIO) today announced that on July 5, 2019, it received notification from Nasdaq that the Company has been granted an additional...
-
Jun 11, 2019Digital Therapeutics leader DarioHealth caps off successful week at the ADA with Two Studies Presenting New Real-World Data in the Field of Diabetes
DarioHealth Corp. (NASDAQ: DRIO), a leading global Digital Therapeutics (DTx) company with connected devices, mobile software and large data solutions presented two studies reporting new...
-
Jun 4, 2019
Functional Medicine Center of Fort Collins, in Fort Collins, CO will incorporate Dario's digital diabetes platform to its health and wellness improvement programs NEW YORK, CAESAREA, Israel and...
-
May 29, 2019Outcomes of several new studies to be released, demonstrating improved life with diabetes.
Global digital therapeutics (DTx) innovator, DarioHealth Corp. (NASDAQ: DRIO), today announced its participation at the annual conference of the American Diabetes Association (ADA) in San Francisco on